, Tracking Stock Market Picks
Enter Symbol:
Pharmacyclics, Inc. (PCYC) [hlAlert]

up 298.30 %

Pharmacyclics, Inc. (PCYC) downgraded to Hold by BWS Financial

Posted on: Friday,  Feb 12, 2010  9:25 AM ET by BWS Financial

BWS Financial rated Hold Pharmacyclics, Inc. (NASDAQ: PCYC) on 02/12/2010. Previously BWS Financial rated Buy Pharmacyclics, Inc. (NASDAQ: PCYC) on 10/13/2008.,
when the stock price was $1.18. Since then, Pharmacyclics, Inc. has gained 298.31% as of 02/12/2010's recent price of $4.70.
If you would have followed the previous BWS Financial's recommendation on PCYC, you would have gained 298.3% of your investment in 487 days.

Pharmacyclics Inc. is a pharmaceutical company developing products to improve upon therapeutic approaches to cancer, atherosclerosis and retinal disease. The company's products are ring-shaped small molecules called texaphyrins. These patented agents are derived from Pharmacyclics' versatile technology platform for designing and synthesizing energy-potentiating drugs. The texaphyrins localize in cancer cells, atherosclerotic plaque and neovasculature, where they can be activated by forms of energy, including X-rays and light to reduce diseased tissue.

· BWS Financial is a Los Angeles based independent stock research firm, which focuses primarily on undervalued companies with little or no street coverage, within the biotechnology, healthcare and technology industries. · BWS Financial focuses on companies that hold much potential in their industries, either through their product pipeline or technological innovations. · BWS Financial’s strategy is not to only specialize in a particular group of stocks, but to also provide investors with insight into other ideas where there is considerable misvaluation.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/12/2010 9:25 AM Hold
as of 12/31/2010
1 Week   
1 Month   
3 Months   
1 YTD up  49.68 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/13/2008 9:25 AM Buy
1.18 2.00
8/17/2007 9:25 AM Hold
2.05 2.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy